Oliver Sartor, M.D.
C.E. and Bernadine Laborde Professor of Cancer Research
Professor, Department of Medicine: Section of Hematology & Medical Oncology and Department of Urology
Assistant Dean for Oncology, Tulane University School of Medicine
Medical Director, Tulane Cancer Center
Associate Director for Clinical Programs, Tulane Cancer Center
Tulane Cancer Center Program Member
Address: 1430 Tulane Ave., SL-42, New Orleans, LA 70112
Dr. Oliver Sartor is an internationally recognized expert in prostate cancer. His medical practice and research have focused on prostate cancer since 1990 when he finished a fellowship at the National Cancer Institute (NCI). He has published over 300 articles and book chapters and led multiple national and international clinical trials as either a principal investigator or co-principal investigator. In particular he has helped to lead pivotal trials leading to FDA approval for samarium-153 EDTMP, radium-223, and cabazitaxel. He has lectured widely, and at last count has given invited lectures in 28 countries.
He is currently the Assistant Dean for Oncology at Tulane University School of Medicine, Medical Director of the Tulane Cancer Center and the Laborde Professor for Cancer Research, with appointments in both the Medicine and Urology Departments.
He has served as the past Chairman of the Department of Defense Prostate Cancer Integration Panel, is currently Editor-in-Chief of the peer-reviewed journal Clinical Genitourinary Cancer, and is the Medical Oncology Chair of the GU committee of NRG. He is also currently a member of the NCI Board of Scientific Counselors (Clinical Sciences and Epidemiology).
Dr. Sartor's publications can be viewed here »
ALSYMPCA Study Protocol & Statistical Analysis Plan »